Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene S Tan

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Virology|December 8, 2004
Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approachGene S Tan, Philip M McKenna, Martin L Koser, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Unveiling the Microbial Realm with VEBA 2.0: A modular bioinformatics suite for end-to-end genome-resolved prokaryotic, (micro)eukaryotic, and viral multi-omics from either short- or long-read sequencingJosh L Espinoza, Allan Phillips, Melanie B Prentice, et al.
Nucleic Acids Research|June 23, 2024
Unveiling the microbial realm with VEBA 2.0: a modular bioinformatics suite for end-to-end genome-resolved prokaryotic, (micro)eukaryotic and viral multi-omics from either short- or long-read sequencingJosh L Espinoza, Allan Phillips, Melanie B Prentice, et al.
Journal of Virology|March 9, 2012
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypesRong Hai, Florian Krammer, Gene S Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2016
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contactPaul E Leon, Wenqian He, Caitlin E Mullarkey, et al.
Mbio|March 12, 2015
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in miceTeddy John Wohlbold, Raffael Nachbagauer, Haoming Xu, et al.
The Journal of Infectious Diseases|September 22, 2009
Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primatesJonathan Cenna, Meredith Hunter, Gene S Tan, et al.
Journal of Visualized Experiments : Jove|September 6, 2017
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal AntibodiesPaul E Leon, Teddy John Wohlbold, Wenqian He, et al.
Mbio|March 27, 2020
Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster ModelJames Duehr, Meagan McMahon, Brandi Williamson, et al.
Cell|July 4, 2015
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine EfficacyTaia T Wang, Jad Maamary, Gene S Tan, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Virology|December 8, 2004
Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approachGene S Tan, Philip M McKenna, Martin L Koser, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Unveiling the Microbial Realm with VEBA 2.0: A modular bioinformatics suite for end-to-end genome-resolved prokaryotic, (micro)eukaryotic, and viral multi-omics from either short- or long-read sequencingJosh L Espinoza, Allan Phillips, Melanie B Prentice, et al.
Nucleic Acids Research|June 23, 2024
Unveiling the microbial realm with VEBA 2.0: a modular bioinformatics suite for end-to-end genome-resolved prokaryotic, (micro)eukaryotic and viral multi-omics from either short- or long-read sequencingJosh L Espinoza, Allan Phillips, Melanie B Prentice, et al.
Journal of Virology|March 9, 2012
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypesRong Hai, Florian Krammer, Gene S Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2016
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contactPaul E Leon, Wenqian He, Caitlin E Mullarkey, et al.
Mbio|March 12, 2015
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in miceTeddy John Wohlbold, Raffael Nachbagauer, Haoming Xu, et al.
The Journal of Infectious Diseases|September 22, 2009
Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primatesJonathan Cenna, Meredith Hunter, Gene S Tan, et al.
Journal of Visualized Experiments : Jove|September 6, 2017
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal AntibodiesPaul E Leon, Teddy John Wohlbold, Wenqian He, et al.
Mbio|March 27, 2020
Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster ModelJames Duehr, Meagan McMahon, Brandi Williamson, et al.
Cell|July 4, 2015
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine EfficacyTaia T Wang, Jad Maamary, Gene S Tan, et al.
Pageof 9